查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609616

药物测试市场规模、份额、趋势分析报告：按产品、按样品、按药物、按最终用途、按地区、细分市场预测，2025-2030 年

Drug Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Sample (Urine Samples), By Drug (Alcohol, Opioids), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

药物测试市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球药物检测市场规模预计将达到186.2亿美元，预计2025年至2030年复合年增长率为5.1%。

创新测试的引入、强制药物测试的严格法规、药物滥用和成瘾的增加是预计在预测期内推动市场成长的一些因素。

药物滥用和成瘾是一个全球性问题，影响着数百万人。根据毒品和犯罪问题办公室发布的《世界毒品报告》，2019年全球整体约有3,500万人患有吸毒障碍。如此高的药物滥用和药物使用障碍发生率对预防、治疗和管理此类病例的创新测试产生了巨大的需求。该领域的几家主要企业正在推出创新、高效的产品来满足这一不断增长的需求。

例如，2019 年 6 月，Quidel Corporation 获得美国FDA 510(k) 许可，可以销售萤光免疫测量- Quidel Triage TOX Drug Screen, 94600。这是为了检测尿液中是否有代谢物和药物。此外，2020 年 6 月，Cordant Health Solutions 提供了视讯观察口腔液体药物测试，以协助法院和政府机构在 COVID-19 大流行期间监测参与者。这有助于应对大流行期间药物滥用障碍患者面临的一些挑战。

政府为确保安全且不断努力并实施严格的药物滥用检测法规，这增加了对检测产品的需求。 2020 年 7 月，纽西兰政府推出了新立法，赋予警方对司机进行随机路边药物测试的权力，以减少该国的酒后驾驶。根据新法案，口腔液测试可以检查促进剂中是否含有古柯碱、摇头丸、大麻、鸦片、甲基安非他命和苯二氮平类药物等物质。此外，2020 年 2 月，印度民航总局对飞行员和机组人员进行了对阿片类药物和大麻等精神活性物质的广泛测试，以确保安全的航空旅行。

药物测试市场报告亮点

  • 到2024年，消耗品业务将占据最大的收益占有率，达到34.6%。耗材对于测试至关重要，包括各种物品，如试剂、管柱、套件、校准品、检体、蓝色染料锭剂、温度试纸、品管等。
  • 尿液检体检体市场占比最大，2024年为77.7%。
  • 2024 年，大麻/大麻细分市场占据主导地位。该细分市场占整个市场的57.5%。这是由于世界各地越来越多地使用大麻和大麻作为非法药物，从而产生了对此类套件和设备的需求。
  • 2024年，药物检测实验室领域占据市场主导地位。这是由于药物检测机构的大量存在和提供的服务。这些实验室的优势包括拥有高效液相层析(HPLC) 和光谱学等先进设备，以及经过培训的人员来进行有效的测试。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 药物检测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 药品检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 药品检测市场：产品预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球药物检测市场前景
  • 2018-2030年市场规模、预测及趋势分析
    • 消耗品
    • 装置
    • 快速检测装置
    • 服务

第五章 药品检验市场：样本估计与趋势分析

  • 2023年及2030年市场占有率样本
  • 细分仪表板
  • 按样本分類的全球药物检测市场前景
  • 2018-2030年市场规模、预测及趋势分析
    • 尿液样本
    • 口腔液样本
    • 头髮样本
    • 其他样品

第六章 药品检验市场：药品估算及趋势分析

  • 2023年及2030年药品市场占有率
  • 细分仪表板
  • 按药物前景分類的全球药物检测市场
  • 2018-2030年市场规模、预测及趋势分析
    • 酒精
    • 大麻/大麻
    • 古柯碱
    • 阿片类药物
    • 安非他命和甲基安非他命
    • LSD
    • 其他的

第七章药物测试市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球药物测试市场展望
  • 2018-2030年市场规模、预测及趋势分析
    • 药物检测实验室
    • 工作场所
    • 医院
    • 其他的

第八章药物检测市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2024年主要企业市场占有率分析
    • Quest Diagnostics Incorporated
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Laboratory Corporation of America Holdings
    • Clinical Reference Laboratory, Inc.
    • Cordant Health Solutions
Product Code: GVR-4-68039-364-2

Drug Testing Market Growth & Trends:

The global drug testing market size is estimated to reach USD 18.62 billion by 2030, registering to grow at a CAGR of 5.1% from 2025 to 2030 according to a new report by Grand View Research, Inc. The introduction of innovative tests, stringent regulation mandating drug testing, and growing substance abuse & addiction are some of the factors anticipated to foster market growth during the forecast period.

Drug abuse and addiction is a global problem, affecting millions of people. As per the World Drug Report published by UNODC, in 2019, around 35.0 million people were suffering from drug use disorders globally. Such a high rate of drug abuse and substance use disorders has created a major demand for innovative tests to prevent, treat, and manage such cases. Several key players operating in this space are introducing innovative and efficient products to meet this growing demand.

For instance, in June 2019, Quidel Corporation received the U.S. FDA's 510(k) clearance to market its fluorescence immunoassay-Quidel Triage TOX Drug Screen, 94600. This is intended for detecting the presence of metabolites or drugs in urine. Moreover, in June 2020, Cordant Health Solutions offered video-observed oral fluid drug testing to help courts & government agencies to monitor participants during the COVID-19 pandemic. This aided in combating several challenges faced by people with substance abuse disorders during the pandemic.

Continuous government initiatives and implementation of strict substance abuse testing regulations to ensure safety have derived the demand for its testing products. In July 2020, the New Zealand government introduced a new bill that provides police the power to conduct random roadside drug testing of drivers to reduce impaired driving in the country. The new bill allows usage of oral fluid tests to check drivers for substances such as cocaine, ecstasy, cannabis, opiates, methamphetamine, and benzodiazepines. Also, in February 2020, the Directorate General of Civil Aviation in India introduced extensive tests for pilots and flight crew members for psychoactive substances such as opioids & cannabis to ensure safe air travel.

Drug Testing Market Report Highlights:

  • The consumables segment captured the largest revenue share of 34.6% in 2024. Consumables are vital for testing and encompass a variety of items, including reagents, columns, kits, calibrators, specimens, blue dye tablets, temperature test strips, and controls.
  • Urine samples segment accounted for the largest share of 77.7% in 2024, primarily due to their widespread acceptance and reliability.
  • The cannabis/marijuana segment dominated the market in 2024. The segment accounted for 57.5% of the overall market. This can be attributed to the increasing use of marijuana or cannabis as an illicit drug in the world, creating a demand for its kits and instruments.
  • The drug testing laboratories segment dominated the market in 2024. This can be attributed to drug testing laboratories' large presence and offerings. Advantages of these laboratories include the availability of sophisticated equipment, such as High-Performance Liquid Chromatography (HPLC) & spectroscopy, and trained personnel for conducting tests for effective results.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Sample
    • 1.2.3. Drug
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Sample outlook
    • 2.2.3. Drug outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of substance abuse
      • 3.2.1.2. Stringent laws mandating alcohol and drug testing
      • 3.2.1.3. Increasing government initiatives to monitor substance abuse
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
  • 3.3. Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Drug Testing Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Drug Testing Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Consumables
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Rapid Testing Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Services
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Drug Testing Market: Sample Estimates & Trend Analysis

  • 5.1. Sample Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Drug Testing Market by Sample Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Urine samples
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Oral fluid samples
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Hair samples
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Other Samples
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Drug Testing Market: Drug Estimates & Trend Analysis

  • 6.1. Drug Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Drug Testing Market by Drug Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Alcohol
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Cannabis/Marijuana
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Cocaine
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Opioids
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Amphetamine & Methamphetamine
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. LSD
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Others
      • 6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Drug Testing Market: End use Estimates & Trend Analysis

  • 7.1. Ens Use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Drug Testing Market by End Use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Drug Testing Laboratories
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. Workplaces
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Hospitals
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Drug Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2024
    • 9.3.4. Quest Diagnostics Incorporated
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Abbott
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. F. Hoffmann-La Roche Ltd.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Quidel Corporation
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Thermo Fisher Scientific, Inc
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Siemens Healthcare GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Bio-Rad Laboratories, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Agilent Technologies, Inc.
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Laboratory Corporation of America Holdings
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Clinical Reference Laboratory, Inc.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Cordant Health Solutions
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of abbreviation
  • Table 3 North America drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 6 North America drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 7 North America drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 10 U.S. drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 11 U.S. drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Canada drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 14 Canada drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 15 Canada drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 18 Mexico drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 19 Mexico drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 21 Europe drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 23 Europe drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 24 Europe drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Germany drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 27 Germany drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 28 Germany drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 31 UK drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 32 UK drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 France drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 34 France drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 35 France drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 36 France drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Italy drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 39 Italy drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 40 Italy drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Spain drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 43 Spain drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 44 Spain drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Denmark drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 47 Denmark drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 48 Denmark drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Sweden drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 51 Sweden drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 52 Sweden drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Norway drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 55 Norway drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 56 Norway drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 62 China drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 China drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 64 China drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 65 China drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Japan drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 68 Japan drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 69 Japan drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 70 India drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 71 India drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 72 India drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 73 India drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 74 South Korea drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 76 South Korea drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 77 South Korea drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Australia drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 80 Australia drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 81 Australia drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Thailand drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 84 Thailand drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 85 Thailand drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Latin America drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 87 Latin America drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 88 Latin America drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 89 Latin America drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Brazil drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 91 Brazil drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 92 Brazil drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 93 Brazil drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 96 Argentina drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 97 Argentina drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 98 MEA drug testing market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 100 MEA drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 101 MEA drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 102 MEA drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 105 South Africa drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 106 South Africa drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 113 UAE drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 114 UAE drug testing market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait drug testing market, by sample, 2018 - 2030 (USD Million)
  • Table 117 Kuwait drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 118 Kuwait drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Pathology Laboratories market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Drug testing market: Product movement analysis
  • Fig. 12 Drug testing market: Product outlook and key takeaways
  • Fig. 13 Consumables market estimates and forecast, 2018 - 2030
  • Fig. 14 Instruments estimates and forecast, 2018 - 2030
  • Fig. 15 Rapid Testing Devices market estimates and forecast, 2018 - 2030
  • Fig. 16 Services estimates and forecast, 2018 - 2030
  • Fig. 17 Drug testing market: Sample movement Analysis
  • Fig. 18 Drug testing market: Sample outlook and key takeaways
  • Fig. 19 Urine samples market estimates and forecasts, 2018 - 2030
  • Fig. 20 Hair samples market estimates and forecasts, 2018 - 2030
  • Fig. 21 Oral fluid samples market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others samples market estimates and forecasts, 2018 - 2030
  • Fig. 23 Drug testing market: drug movement analysis
  • Fig. 24 Drug testing market: drug outlook and key takeaways
  • Fig. 25 Alcohol market estimates and forecasts, 2018 - 2030
  • Fig. 26 Cannabis/Marijuana market estimates and forecasts, 2018 - 2030
  • Fig. 27 Cocaine market estimates and forecasts, 2018 - 2030
  • Fig. 28 Opioids market estimates and forecasts, 2018 - 2030
  • Fig. 29 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030
  • Fig. 30 Other market estimates and forecasts, 2018 - 2030
  • Fig. 31 Drug testing market: end use movement analysis
  • Fig. 32 Drug testing market: end use outlook and key takeaways
  • Fig. 33 Drug testing laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 34 Workplaces market estimates and forecasts, 2018 - 2030
  • Fig. 35 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030
  • Fig. 37 Global drug testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 43 UK market estimates and forecasts, 2018 - 2030
  • Fig. 44 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 45 France market estimates and forecasts, 2018 - 2030
  • Fig. 46 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 47 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 49 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 50 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 51 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 52 China market estimates and forecasts, 2018 - 2030
  • Fig. 53 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 54 India market estimates and forecasts, 2018 - 2030
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 57 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 58 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 59 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 61 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 66 Market share of key market players- Drug testing market